Αποτελέσματα Αναζήτησης
19 Ιουν 2024 · This web page reviews the management of hypertriglyceridemia, a common lipid disorder that increases cardiovascular risk. It does not provide specific information on triglyceride lowering medication, but refers to other topics for more details.
- Mason W Freeman, MD
Deputy Editors Susan B Yeon, MD, JD Deputy Editor —...
- Virani Ss, Morris Pb, Agarwala A, Et Al. 2021 ACC Expert Consensus Decision Pathway on The Management of Ascvd Risk Reduction in Patients With Persistent Hypertriglyceridemia: a Report of The American College of Cardiology Solution Set Oversight Committee. J Am Coll Cardiol 2021; 78:960
1 PubMed | TI 2021 ACC Expert Consensus Decision Pathway on...
- Skulas-Ray Ac, Wilson Pwf, Harris Ws, Et Al. Omega-3 Fatty Acids for The Management of Hypertriglyceridemia: a Science Advisory From The American Heart Association. Circulation 2019; 140:E673
When used to treat hypertriglyceridemia, n-3 FAs with...
- Bhatt Dl, Steg Pg, Miller M, Et Al. Cardiovascular Risk Reduction With Icosapent Ethyl for Hypertriglyceridemia. N Engl J Med 2019; 380:11
METHODS We performed a multicenter, randomized,...
- Eckel Rh, Jakicic Jm, Ard Jd, Et Al. 2013 Aha/Acc Guideline on Lifestyle Management to Reduce Cardiovascular Risk: a Report of The American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation 2014; 129:S76
11 PubMed | TI 2013 AHA/ACC guideline on lifestyle...
- Keech A, Simes Rj, Barter P, Et Al. Effects of Long-Term Fenofibrate Therapy on Cardiovascular Events in 9795 People With Type 2 Diabetes Mellitus (The Field Study): Randomised Controlled Trial. Lancet 2005; 366:1849
We designed the Fenofibrate Intervention and Event Lowering...
- Rosenson Rs. Fenofibrate: Treatment of Hyperlipidemia and Beyond. Expert Rev Cardiovasc Ther 2008; 6:1319
15 PubMed | TI Fenofibrate: treatment of hyperlipidemia and...
- Nicholls Sj, Lincoff Am, Garcia M, Et Al. Effect of High-Dose Omega-3 Fatty Acids vs Corn Oil on Major Adverse Cardiovascular Events in Patients at High Cardiovascular Risk: The Strength Randomized Clinical Trial. JAMA 2020; 324:2268
49 PubMed | TI Effect of High-Dose Omega-3 Fatty Acids vs...
- Mason W Freeman, MD
1 Σεπ 2022 · Learn about the causes and risks of high triglycerides, and how to lower them with lifestyle changes and medications. Find out how icosapent ethyl, a prescription drug derived from fish oil, can reduce the risk of heart attack and stroke.
15 Σεπ 2020 · Learn how to lower triglyceride levels and reduce cardiovascular risk with diet, exercise, and medications. Find out when to use statins, icosapent, fibrates, omega-3 fatty acids, or niacin for different triglyceride levels and risk factors.
11 Ιαν 2019 · The 2018 ACC/AHA classifies moderate hypertriglyceridemia as 150-499 mg/dL and severe hypertriglyceridemia as 500 mg/dL or more. The ESC/EAS guideline also classifies fasting TGs of <150 mg/dL (1.7 mmol/L) as desirable, noting that about one-third of individuals have levels 150 mg/dL or above.
18 Ιαν 2024 · Here we discuss the drugs used for the treatment of hypertriglyceridemia: (niacin, fibrates, omega-3-fatty acids, volanesorsen (available in Europe) and lipoprotein lipase gene therapy (alipogene tiparvovec- no longer available). Niacin decreases total cholesterol, TGs (20-50% decrease), LDL-C, and Lp (a).
7 Μαρ 2024 · Several types of prescription medications are available to treat cholesterol and lower triglyceride levels. Statins are the first-line therapy for reducing cholesterol. These drugs work by reducing the liver's ability to make cholesterol.
12 Οκτ 2020 · Hypertriglyceridemia is one of the most common lipid abnormalities encountered in clinical practice. Many monogenic disorders causing severe hypertriglyceridemia have been identified, but in most patients triglyceride elevations result from a combination of multiple genetic variations with small effects and environmental factors.
